These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19901153

  • 1. The case for dual Renin-Angiotensin system inhibition.
    Hirsch S.
    Arch Intern Med; 2009 Nov 09; 169(20):1931; author reply 1931. PubMed ID: 19901153
    [No Abstract] [Full Text] [Related]

  • 2. [Dual blockade of the renin-angiotensin system].
    Andersen NH, Mogensen CE.
    Ugeskr Laeger; 2004 Oct 18; 166(43):3799-803. PubMed ID: 15544108
    [No Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S.
    Compr Ther; 2009 Oct 18; 35(2):91-5. PubMed ID: 19618757
    [Abstract] [Full Text] [Related]

  • 4. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL, Townsend RR.
    J Am Soc Nephrol; 2009 Aug 18; 20(8):1666-8. PubMed ID: 18776118
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?
    Strauss MH, Verma S.
    Can J Cardiol; 2005 May 15; 21(7):577-80. PubMed ID: 15940355
    [No Abstract] [Full Text] [Related]

  • 6. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
    Berl T.
    Nephrol Dial Transplant; 2008 Aug 15; 23(8):2443-7. PubMed ID: 18467376
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V.
    Am Heart J; 2009 Jun 15; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [Abstract] [Full Text] [Related]

  • 8. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Bakris GL, Weir MR.
    Postgrad Med; 2008 Apr 15; 120(1):33-42. PubMed ID: 18467807
    [Abstract] [Full Text] [Related]

  • 9. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH, Papademetriou V.
    Am Heart J; 2009 Jun 15; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [Abstract] [Full Text] [Related]

  • 10. Dual renin-angiotensin system blockade: in patients with single functioning kidney and proteinuria.
    Robles NR, Ruiz Jiménez B, Hernández Gallego R, Ruiz-Calero R, Sánchez Casado E, Cubero JJ.
    Eur J Intern Med; 2009 Mar 15; 20(2):186-9. PubMed ID: 19327610
    [Abstract] [Full Text] [Related]

  • 11. Dual renin-angiotensin system blockade: on the target.
    Robles NR.
    Int J Clin Pract; 2008 Aug 15; 62(8):1134-6. PubMed ID: 18705817
    [No Abstract] [Full Text] [Related]

  • 12. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E, Park J, Vidhun J, Campese V.
    Arch Intern Med; 2009 Jun 08; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract] [Full Text] [Related]

  • 13. The renin-angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease.
    Brugts JJ, den Uil CA, Danser AH, Boersma E.
    Cardiology; 2009 Jun 08; 112(4):303-12. PubMed ID: 18832826
    [Abstract] [Full Text] [Related]

  • 14. [The early diagnosis of kidney failure in diabetic patients and the new developments in its treatment].
    Eliseev OM.
    Ter Arkh; 1995 Jun 08; 67(4):66-9. PubMed ID: 7784984
    [No Abstract] [Full Text] [Related]

  • 15. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E.
    Am Heart J; 2009 Jun 08; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
    Palmer BF.
    Nephrol Dial Transplant; 2003 Oct 08; 18(10):1973-5. PubMed ID: 13679467
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin and its inhibition: a nephrologist point of view.
    Kalra V, Agarwal SK, Wani M.
    J Assoc Physicians India; 2002 Oct 08; 50():1270-80. PubMed ID: 12568213
    [No Abstract] [Full Text] [Related]

  • 18. Treating diabetic nephropathy: unfinished success is not failure.
    Lewis J.
    Clin J Am Soc Nephrol; 2007 May 08; 2(3):407-9. PubMed ID: 17699442
    [No Abstract] [Full Text] [Related]

  • 19. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S, Komers R.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract] [Full Text] [Related]

  • 20. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
    Boos CJ, Lip GY.
    J Hum Hypertens; 2005 Nov 04; 19(11):855-9. PubMed ID: 16094406
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.